Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
US government orders 2.5M more monkeypox vaccine doses from Bavarian Nordic via CMO
3 years ago
Manufacturing
Merck KGaA kicks off startup collaboration program in Asia
3 years ago
Pfizer celebrates a new FDA approval as the Xalkori franchise slowly winds down
3 years ago
FDA+
J&J objects to Sanofi’s '#1 Doctor Recommended' claims about heartburn drug Zantac
3 years ago
Marketing
Illumina strikes $325M deal to end years-long patent battles
3 years ago
Law
Pfizer's Hospira issues a recall for a batch of propofol due to a visible particulate
3 years ago
FDA+
Manufacturing
As the consumer group splits away today, what will New GSK buy now?
3 years ago
Bioregnum
Pfizer sues Amgen in effort to invalidate top cancer drug patent
3 years ago
Law
Manchin plays spoiler again, but drug pricing reforms remain on the table
3 years ago
Law
Drug shortages remain low in 2021 as FDA's prevention efforts grow, report to Congress says
3 years ago
FDA+
Cancer Moonshot moves forward with new 'Cancer Cabinet' and goals to reduce cancer
3 years ago
People
Bayer sells testosterone treatment to German company for $500M
3 years ago
Deals
Happify rebrands as Twill, weaving a new name for its expanded digital health and pharma business
3 years ago
Marketing
Pharma hiring continues to grow in the US and talent competition remains tight — report
3 years ago
People
Otsuka sponsors Ken Burns' PBS youth and mental illness documentary to drive awareness and dispel stigma
3 years ago
Marketing
European Ombudsman upholds 'maladministration' finding over missing Pfizer CEO texts
3 years ago
Ultragenyx sells $500M in royalty interest on rare disease drug to Canadian pension plan
3 years ago
Deals
Illumina loses challenge to block EU antitrust probe into $8B Grail buyout
3 years ago
Deals
Novartis’ $650M cash bet on a near-term FDA OK for BeiGene’s China PD-1? It just got delayed indefinitely
3 years ago
China
FDA+
In post-Roe guidance, HHS tells 60,000 pharmacies: Don't stop dispensing abortion drugs
3 years ago
Law
Amid global expansion, Samsung Biologics pledges emissions drops in new ESG report
3 years ago
Manufacturing
Sanofi CEO Paul Hudson offloads two portfolios to German pharma company in continued effort to prune products
3 years ago
Deals
Vivus’ Qsymia beats out weight loss competitors in pricing watchdog's latest cost-effectiveness analysis
3 years ago
Alnylam sues Moderna and Pfizer again over Covid-19 vaccine patent infringement
3 years ago
Law
First page
Previous page
187
188
189
190
191
192
193
Next page
Last page